PDC*line Pharma completes enrolment of four cohorts of patients in PDC-LUNG-101 phase I/II clinical trial
stephanie.dhont2023-12-06T15:54:43+01:00PDC*line Pharma, a clinical stage biotech company developing a new [...]
PDC*line Pharma, a clinical stage biotech company developing a new [...]
Download here the latest MATWIN newsletter :
Interview of Benjamin GAREL, General Manager of Paris Saclay Cancer [...]
You dream of taking part in an exciting and meaningful [...]
A unique committee in Europe, the MATWIN Board is made [...]
Download the press release:
MATWIN and the Paris Saclay Cancer Cluster join their forces [...]
BiPer Therapeutics, awarded during OUI (Oncology Upward Investment) 2021 edition [...]
MATWIN and the European Health Investor Network announce their new [...]
Genoscience Pharma, supported by MATWIN in 2021, receives FDA orphan [...]